Cambridge, MA, United States of America

Rebecca L Casaubon

This inventor holds 6 USPTO granted patents and 11 published patent applications and 3 EPO patents. Top assignees: Glaxosmithkline LLC, Forma Therapeutics, Inc.. Active years: 2012-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rebecca L Casaubon. Retrieved from https://idiyas.com/inventor/rebecca-l-casaubon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 33.3

 

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Chestnut Hill, MA (US) (2013)
  • Cambridge, MA (US) (2012 - 2018)
  • Garnet Valley, PA (US) (2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Rebecca L Casaubon

Introduction

Rebecca L Casaubon is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate sirtuins, which are proteins involved in cellular regulation and longevity. With a total of 6 patents to her name, her work has the potential to impact various health-related issues.

Latest Patents

Among her latest patents, Casaubon has developed "Substituted bridged urea analogs as sirtuin modulators." This invention relates to novel substituted bridged urea compounds and their pharmaceutical applications. These compounds may be utilized to increase the lifespan of cells and treat a range of diseases, including those related to aging, diabetes, obesity, and cancer. Another significant patent is "Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators." This invention also focuses on compounds that can enhance cellular lifespan and address various health disorders.

Career Highlights

Throughout her career, Casaubon has worked with notable companies such as GlaxoSmithKline LLC and Forma Therapeutics, Inc. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Casaubon has collaborated with esteemed colleagues, including Christopher Oalmann and Charles A Blum. These partnerships have further enriched her research and innovation efforts.

Conclusion

Rebecca L Casaubon exemplifies the spirit of innovation in the pharmaceutical field. Her patents and collaborative efforts highlight her commitment to advancing health solutions through scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…